|
RELA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.63859999977734E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.23549999809481E-08 |
| Normal-vs-Stage2 |
2.703600E-02 |
| Normal-vs-Stage3 |
2.298500E-03 |
| Normal-vs-Stage4 |
2.789100E-04 |
| Stage1-vs-Stage2 |
1.412810E-01 |
| Stage1-vs-Stage3 |
5.084100E-02 |
| Stage1-vs-Stage4 |
3.021800E-01 |
| Stage2-vs-Stage3 |
9.457600E-01 |
| Stage2-vs-Stage4 |
5.897400E-01 |
| Stage3-vs-Stage4 |
5.091400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62911999999071E-05 |
| Normal-vs-AfricanAmerican |
2.116100E-03 |
| Normal-vs-Asian |
5.231000E-01 |
| Caucasian-vs-AfricanAmerican |
5.902200E-01 |
| Caucasian-vs-Asian |
3.254200E-01 |
| AfricanAmerican-vs-Asian |
3.609400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.226700E-04 |
| Normal-vs-Female |
3.38129999555292E-08 |
| Male-vs-Female |
6.577600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.079980E-01 |
| Normal-vs-Age(41-60Yrs) |
1.41419999999393E-06 |
| Normal-vs-Age(61-80Yrs) |
1.947059999996E-05 |
| Normal-vs-Age(81-100Yrs) |
8.688000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.637390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.470800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.601800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.381000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.028800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.604000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.87609999979799E-07 |
| Normal-vs-Grade 2 |
6.3114000026232E-08 |
| Normal-vs-Grade 3 |
9.765900E-04 |
| Normal-vs-Grade 4 |
2.816700E-03 |
| Grade 1-vs-Grade 2 |
2.479900E-02 |
| Grade 1-vs-Grade 3 |
8.821800E-04 |
| Grade 1-vs-Grade 4 |
4.610700E-04 |
| Grade 2-vs-Grade 3 |
1.352350E-02 |
| Grade 2-vs-Grade 4 |
4.353600E-02 |
| Grade 3-vs-Grade 4 |
9.723000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.78100001202841E-09 |
| Normal-vs-ccB subtype |
6.879700E-03 |
| ccA subtype-vs-ccB subtype |
1.376520E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.93780000000188E-05 |
| Normal-vs-N1 |
7.236500E-02 |
| N0-vs-N1 |
8.511000E-01 |
|
|
